These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 2522912

  • 21. Immunological effects of interferon-alpha on chronic myelogenous leukemia.
    de Castro FA, Palma PV, Morais FR, Simões BP, Carvalho PV, Ismael SJ, Lima CP, Voltarelli JC.
    Leuk Lymphoma; 2003 Dec; 44(12):2061-7. PubMed ID: 14959848
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Functional integrity of T, B, and natural killer cells in homosexual subjects with prodromata and in patients with AIDS.
    Bekesi JG, Tsang P, Lew F, Roboz JP, Teirstein A, Selikoff IJ.
    Ann N Y Acad Sci; 1984 Dec; 437():28-38. PubMed ID: 6335953
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Numerical and functional alterations of lymphocytes in human schistosomiasis.
    Gastl GA, Feldmeier H, Doehring E, Kortmann C, Daffalla AA, Peter HH.
    Scand J Immunol; 1984 May; 19(5):469-79. PubMed ID: 6233696
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Partial correction of defective generation of lymphokine-activated killer cells in patients with chronic myelogenous leukaemia after in vivo treatment with interferon-alpha (Wellferon).
    Pawelec G, Schneider E, Ehninger G, Rehbein A, Schmidt H.
    Cancer Immunol Immunother; 1989 May; 29(1):63-6. PubMed ID: 2785001
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. TCR zeta chain expression in T cells from patients with CML.
    Chen S, Yang L, Chen S, Li Y.
    Hematology; 2009 Apr; 14(2):95-100. PubMed ID: 19298721
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Production of interleukin-2 (IL-2) and expression of IL-2 receptor in patients with IgA nephropathy.
    Lee TW, Kim MJ.
    Korean J Intern Med; 1992 Jan; 7(1):31-8. PubMed ID: 1477028
    [Abstract] [Full Text] [Related]

  • 35. Number of activated T-helper cells and NK cells in peripheral blood is decreased in severe Crohn's disease.
    Kontiainen S, Scheinin T, Halme L.
    APMIS; 1996 May; 104(5):355-61. PubMed ID: 8703441
    [Abstract] [Full Text] [Related]

  • 36. The role of autologous natural killer cells in chronic myelogenous leukemia.
    Pierson BA, Miller JS.
    Leuk Lymphoma; 1997 Nov; 27(5-6):387-99. PubMed ID: 9477121
    [Abstract] [Full Text] [Related]

  • 37. Phenotypic and functional characterization of the host immune compartment of chronic myeloid leukaemia patients in complete haematological remission.
    Guarini A, Breccia M, Montefusco E, Petti MC, Zepparoni A, Vitale A, Foa R.
    Br J Haematol; 2001 Apr; 113(1):136-42. PubMed ID: 11328293
    [Abstract] [Full Text] [Related]

  • 38. Impaired natural killer cytotoxicity in peripheral blood mononuclear cells in Graves' disease.
    Marazuela M, Vargas JA, Alvarez-Mon M, Albarrán F, Lucas T, Durántez A.
    Eur J Endocrinol; 1995 Feb; 132(2):175-80. PubMed ID: 7858736
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.